0001209191-16-115686.txt : 20160426 0001209191-16-115686.hdr.sgml : 20160426 20160426160625 ACCESSION NUMBER: 0001209191-16-115686 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160425 FILED AS OF DATE: 20160426 DATE AS OF CHANGE: 20160426 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PACIFIC BIOSCIENCES OF CALIFORNIA, INC. CENTRAL INDEX KEY: 0001299130 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 161590339 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1380 WILLOW ROAD CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650-521-8000 MAIL ADDRESS: STREET 1: 1380 WILLOW ROAD CITY: MENLO PARK STATE: CA ZIP: 94025 FORMER COMPANY: FORMER CONFORMED NAME: PACIFIC BIOSCIENCES OF CALIFORNIA INC DATE OF NAME CHANGE: 20050829 FORMER COMPANY: FORMER CONFORMED NAME: NANOFLUIDICS INC DATE OF NAME CHANGE: 20040729 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Phillips James Michael CENTRAL INDEX KEY: 0001504238 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34899 FILM NUMBER: 161592072 MAIL ADDRESS: STREET 1: PACIFIC BIOSCIENCES OF CALIFORNIA, INC. STREET 2: 1380 WILLOW ROAD CITY: MENLO PARK STATE: CA ZIP: 94025 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-04-25 0 0001299130 PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB 0001504238 Phillips James Michael PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 1380 WILLOW ROAD MENLO PARK CA 94025 0 1 0 0 SVP, Research & Development Common Stock 2016-04-25 4 M 0 20000 1.96 A 201449 D Common Stock 2016-04-25 4 S 0 20000 10.286 D 181449 D Stock Option (right to buy) 1.96 2016-04-25 4 M 0 20000 0.00 D 2017-06-21 Common Stock 20000 17500 D The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. This is the weighted average price of the shares sold, which ranged from $10.02 to $10.61 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. 100% of the shares subject to the option are fully vested and exercisable. James Michael Phillips 2016-04-26